Cite
MLA Citation
Miguel Martín et al.. “Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.” European journal of cancer, vol. 168, 2022, pp. 12–24. http://access.bl.uk/ark:/81055/vdc_100155020454.0x000022